Merck KGaA (LON:0O14)

Market Cap	45.79B
Revenue (ttm)	18.19B
Net Income (ttm)	2.45B
Shares Out	n/a
EPS (ttm)	5.65
PE Ratio	18.66
Forward PE	13.91
Dividend	1.87 (1.59%)
Ex-Dividend Date	Apr 28, 2025

Volume	65,499
Average Volume	53,535
Open	118.25
Previous Close	117.70
Day's Range	117.55 - 121.50
52-Week Range	100.90 - 168.35
Beta	0.61
RSI	69.52
Earnings Date	Nov 13, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment also provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and test...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,020
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR